The Long-Term Benefits of Increased Aspirin Use by At-Risk Americans Aged 50 and Older.

about

PCSK9 Inhibitors Show Value for Patients and the US Health Care System.Effect of Health-Promoting Agents on Exclusion-Zone Size

P2860

Q46828082-4AA1FB78-2F88-440D-8E9A-7A29F3D2AA05 Q58768827-9CD83487-CD03-4230-9621-9A0433BF4FC9

P2860

The Long-Term Benefits of Increased Aspirin Use by At-Risk Americans Aged 50 and Older.

Item

http://www.wikidata.org/entity/Q36207970

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

The Long-Term Benefits of Increased Aspirin Use by At-Risk Americans Aged 50 and Older.

@ast

The Long-Term Benefits of Increased Aspirin Use by At-Risk Americans Aged 50 and Older.

@en

type

Item

label

The Long-Term Benefits of Increased Aspirin Use by At-Risk Americans Aged 50 and Older.

@ast

The Long-Term Benefits of Increased Aspirin Use by At-Risk Americans Aged 50 and Older.

@en

prefLabel

The Long-Term Benefits of Increased Aspirin Use by At-Risk Americans Aged 50 and Older.

@ast

The Long-Term Benefits of Increased Aspirin Use by At-Risk Americans Aged 50 and Older.

@en

P1476

The Long-Term Benefits of Increased Aspirin Use by At-Risk Americans Aged 50 and Older.

@en

P2093

Andrew Messali

http://www.w3.org/2001/XMLSchema#string

Dana P Goldman

http://www.w3.org/2001/XMLSchema#string

David B Agus

http://www.w3.org/2001/XMLSchema#string

Étienne Gaudette

http://www.w3.org/2001/XMLSchema#string

P2860

Aspirin for the primary prevention of cardiovascular events: recommendation and rationale

Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials

Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials

The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force

Are investments in disease prevention complements? The case of statins and health behaviors

Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials.

Estimates of benefits and harms of prophylactic use of aspirin in the general population.

Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement.

Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement.

Do Statins Reduce the Health and Health Care Costs of Obesity?

P304

e0166103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0166103

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27902693

http://www.w3.org/2001/XMLSchema#string

P932

5130201

http://www.w3.org/2001/XMLSchema#string

The Long-Term Benefits of Increased Aspirin Use by At-Risk Americans Aged 50 and Older.

about

P2860

P2860

The Long-Term Benefits of Increased Aspirin Use by At-Risk Americans Aged 50 and Older.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932